Bgb-3245 drug page Clinical trials

Trials with Bgb-3245

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
2Countries
13Planned patients

Showing 1–1 of 1

A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers
Finished Phase 1 13 patients NCT06194877

The primary objectives of Part 1 of this study are to: * Assess the safety and tolerability of the combination of BGB-3245 and panitumumab in participants with advanced or metastatic colorectal cancer (CRC) with a known mutation status an…

United States, Australia Apr 2024 – Mar 2025 Interventional
Combined with: Panitumumab